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Abstract
Background:  Pharmacy schools across North America have been charged to ensure their
students are adequately skilled in the principles and practices of pharmaceutical care. Despite this
mandate, a large percentage of students experience insufficient opportunities to practice the
activities, tasks and processes essential to pharmaceutical care. The objective of this retrospective
study of pharmacy students was to: (1) as "proof of concept", test the overall educational impact
of an enhanced advanced pharmacy practice experiential (APPE) model on student competencies;
(2) develop an instrument to measure students' and preceptors' experiences; and (3) assess the
psychometric properties of the instrument.
Methods: A comparative-experimental design, using student and preceptor surveys, was used to
evaluate the impact of the enhanced community-based APPE over the traditional APPE model. The
study was grounded in a 5-stage learning model: (1) an enhanced learning climate leads to (2) better
utilization of learning opportunities, including (3) more frequent student/patient consultation, then
to (4) improved skills acquisition, thence to (5) more favorable attitudes toward pharmaceutical
care practice. The intervention included a one-day preceptor workshop, a comprehensive on-site
student orientation and extending the experience from two four-week experiences in different
pharmacies to one eight-week in one pharmacy.
Results: The 35 student and 38 preceptor survey results favored the enhanced model; with
students conducting many more patient consultations and reporting greater skills improvement. In
addition, the student self-assessment suggested changes in attitudes favoring pharmaceutical care
principles. Psychometric testing showed the instrument to be sensitive, valid and reliable in
ascertaining differences between the enhanced and traditional arms.
Conclusion:  The enhanced experiential model positively affects learning opportunities and
competency acquisition, as measured by a new instrument showing sound psychometric
properties.
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Background
Preventable drug-related problems due to inappropriate
prescribing, under-prescribing, and inappropriate medi-
cation use contribute significantly to both the economic
and human costs of health care [1-4]. Several studies have
demonstrated that pharmacists have a vital role to play in
drug therapy management, thus enhancing overall patient
health outcomes [5-10]. In response to economic and
societal needs, the pharmacy profession throughout
North America has adopted pharmaceutical care as its new
practice mandate. Pharmaceutical care is defined as a phi-
losophy of practice wherein the "pharmacist cooperates
with patients and other professionals in designing, imple-
menting and monitoring therapeutic plans that will pro-
duce specific therapeutic outcomes" [1]. Pharmaceutical
care takes the profession beyond simple drug distributing
and counseling responsibilities to a broader mandate of
patient-centered care to maximize the positive outcomes
of patients' drug therapies. Consequently, the Canadian
Council for Accreditation of Pharmacy Programs has
charged pharmacy schools across Canada to ensure that
students are adequately skilled in the principles and prac-
tices of pharmaceutical care [11].
In 1999, the structured practice education program
(SPEP) at the Faculty of Pharmaceutical Sciences (the Fac-
ulty), University of British Columbia (UBC) – Vancouver,
Canada, used an iterative process involving faculty mem-
bers and UBC pharmacy preceptors to introduce a new
community-based advanced pharmacy practice experi-
ence (APPE) to meet accreditation standards. The new
APPE detailed 13 content domains that emphasized the
specific knowledge, skills and attitudes required to prac-
tice pharmaceutical care; these domains can be summa-
rized under four general themes: (1) developing care
delivery strategies that promote discussing, acquiring and
assessing relevant patient, drug and disease; (2) develop-
ing care plans in collaboration with patients and other
health professionals to prevent or resolve drug-related
problems; (3) assuming responsibility for managing drug-
related problems by monitoring patients' progress and
ensuring follow-up care; and (4) promoting health
through disease prevention and wellness clinics and sem-
inars. Table 1 summarizes the range of specific patient
care activities students are required to engage in for this
APPE. The development process of this new program has
been discussed in detail in a previous publication [12].
As part of the SPEP office's continuous quality improve-
ment initiative, a detailed evaluation of the newly imple-
mented community-based APPE was conducted in 2000
[13,14]. The findings from the evaluation suggested that –
while students had ample opportunity to engage in learn-
ing activities that the pharmacy staff regularly encoun-
Table 1: Community-based advanced pharmacy practice experience activities
PC Competency Domains Activity Description
1. Asking about patient expectations 1. Assess patients with new prescriptions and develop care plans to resolve/prevent drug-
related problems
2. Collecting relevant information 2. Assess patients with refill prescriptions and develop care plans to resolve/prevent drug-
related problems
3. Integrating patient information 3. Present and discuss 1 prescription AND 1 non-prescription drug class with preceptor
4. Evaluating different treatment options 4. Provide pharmaceutical care patients requesting non-prescription products, develop care 
plan for all interventions
5. Documenting patient info: continuity of care 5. Provide follow-up to patients encountered in activities # 1, 2, 4 and 9, document follow-up 
care
6. Prioritizing drug related problems 6. Provide drug information to patients, preceptors and other health care providers, document 
all recommendations
7. Determining patient experiences: 
effectiveness or undesirable effects of current 
medications
7. Shadow another health care professional for 1/2 to 1 day, complete the reflection page
8. Determining whether patients were 
managing and adhering to their medication 
regimes
8. Discuss pharmacy practice issues related to pharmaceutical care (barriers and opportunities
9. Establishing monitoring parameters with 
patients
9. Provide comprehensive pharmaceutical care by assessing all drug-related needs of your 
patient, identify drug-related problems and develop care plans to resolve/prevent drug-related 
problems
10. Following-up patients by phone or in-
person
10. Initiate and complete a patient care project, submit a summary of your project
11. Developing professional relationships: with 
other health care providers, physicians
12. Participating in clinics, seminars, projects 
or presentations
13. Providing basic and comprehensive 
pharmaceutical careBMC Medical Education 2008, 8:17 http://www.biomedcentral.com/1472-6920/8/17
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tered in their practices, such as assessment of new and
refill prescriptions and over-the-counter requests, they
had significantly fewer opportunities to engage in activi-
ties related to comprehensive pharmaceutical care that
included developing and maintaining relationships with
patients, assuming responsibility for the management of
drug-related issues, and evaluating the patients' drug ther-
apy through follow-up care. Student learning was further
hampered by limited opportunities to engage in a variety
of non-direct pharmaceutical care activities, such as inter-
professional collaborations and health promotion/dis-
ease prevention clinics, seminars and presentations.
Interestingly, results from a recent survey found that a
large percentage of students from the United States also
experienced insufficient opportunities to practice the
activities, tasks and processes essential to pharmaceutical
care; suggesting this to be a widespread concern [15].
To enhance UBC students' learning experience during
their community-based APPE, the SPEP faculty undertook
a project to explore structures and processes that could
help promote better congruence with the principles of
pharmaceutical care and the patient care delivery process
the students engaged in. The structures and processes were
introduced in a stepwise fashion, supported by evidence
gathered at different stages of the project. This article
reports on a pilot study focusing on three goals: (1) as
"proof of concept," to test the overall educational impact
of an enhanced APPE model on student competencies; (2)
to develop an instrument to measure how both students
and preceptors experienced the enhanced community-
based model; and (3) to assess the reliability, validity and
discriminating power of the instrument to detect differ-
ences between the traditional and the enhanced APPE
models. The primary hypothesis was that the competency
scores for the enhanced model (treatment arm) would
improve more than would scores for the traditional
model (control arms), and that such improvements
would be evident for both students and their preceptors.
Methods
Design
A retrospective comparative-experimentalist design was
used to evaluate the impact of the enhanced community-
based APPE model on students' learning and performance
[16]. The overall logic of the study was grounded in a 5-
stage learning model: (1) An enhanced learning climate
(trained preceptors, explicit SPEP guidelines, student
training and support) should lead to (2) better utilization
of APPE learning opportunities, including (3) more fre-
quent student/patient consultation, then to (4) improved
skills acquisition, thence to (5) more favorable attitudes
toward pharmaceutical care practice. The study was con-
ducted between September 2001 and May 2002 in com-
munity pharmacies with continuing histories as
placement sites for APPE. Ethics approval had been
obtained through UBC's Office of Research Services and
consent was obtained from all students and preceptors to
allow dissemination and publication of the study's find-
ings.
Participants
This study was grounded in a unique partnership devel-
oped between the University's Pharmacy school and a
nationally operating pharmacy chain. As part of this part-
nership, the national chain had agreed to two important
aspects: (1) to provide release time for their preceptors to
attend a full-day's preceptor training workshop at com-
pany expense; and (2) to support the costs associated with
the delivery of the training program and the evaluation of
the APPE post-training. A student researcher was hired to
manage data collection and collation, and an instrument
developer/statistician was hired to assist with survey
instrument development, data analysis and interpreta-
tion.
The aim of the study was to recruit seven community
pharmacies into the study's treatment arm (enhanced
rotation) and a similar number into each of the two con-
trol arms (traditional rotation). To extend the generaliza-
bility of the study results, one of the control arms
comprised pharmacies from the same national partnering
chain while the second control arm consisted of an assort-
ment of community pharmacies from other chains and
independent pharmacies. Purposeful selection was used
to recruit the pharmacies, ensuring representation from
both urban and rural settings; all sites had a long history
of serving as placement sites for UBC. The community
pharmacies in the two control arms were matched to the
enhanced pharmacies in terms of geographic location and
community size, and all had previously served as place-
ment sites with UBC. All recruited pharmacies were asked
to designate one pharmacist to serve as the primary pre-
ceptor, whose responsibility would be to set the clerkship
expectations with the student, facilitate learning opportu-
nities, provide on-going feedback and conduct the mid-
point and final evaluation of the student. In addition,
other pharmacists were also encouraged to participate in
the student's learning if they were interested in doing so;
these pharmacists served as secondary preceptors and
worked within the framework established by the primary
preceptor. Student participation in the enhanced arm was
voluntary because its structure was new to the curriculum,
would require additional student commitment beyond
the traditional rotation, and its impact had not yet been
assessed. The enhanced APPE was advertised to all fourth-
year (senior year) students through e-mail and class pres-
entations, and interested students were recruited on a
first-come basis. Each placement site (enhanced and con-BMC Medical Education 2008, 8:17 http://www.biomedcentral.com/1472-6920/8/17
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trol) accepted a maximum of two students at different
times within the academic year.
Intervention
During their 8-week community-based APPE, students in
both the enhanced and control sites were expected to
meet similar learning objectives, participate in the same
learning activities, and were held to the same learning and
performance criteria and evaluation standards.
Students and preceptors in both control arms received the
SPEP manual outlining the APPE's learning activities,
expectations, policies, evaluation processes and forms,
patient care tools and conduct standards. The APPE dura-
tion for the control arm students comprised of two 4-week
cycles at two different pharmacy locations. The control
students participated in a mandatory 3-hour face-to-face
orientation session and an on-line quiz reinforcing the
APPE expectations, but no additional intervention was
provided to the control preceptors other than the routine
verbal and written communications that occurs between
the SPEP office and the preceptors.
Primary preceptors and students in the enhanced arm
were provided with a few additional interventions beyond
those offered to the control arm. The intervention con-
sisted of separately structured experiences for both stu-
dents and preceptors: (1) a one-day preceptor education
workshop to discuss the proposed pharmaceutical care
practice model, to review the course syllabus, to clarify the
learning tasks expected of students, and to work through
an ice-breaker exercise to be conducted with their stu-
dents; (2) a five-day student orientation at the pharmacy
site prior to the start of the practice education experience
to allow pharmacists to assess their students' baseline
competencies with various distribution activities and
selected pharmaceutical care activities outlined in Table 1
(specifically activities: # 1, 2, 4, 6 and 9); and (3) extend-
ing the experience from the traditional two 4-week rota-
tions completed at two different pharmacies to one 8-
week experience completed at the same enhanced arm
pharmacy.
Instrument Development
A 70-item, 5-point Likert-type survey was developed
around the pharmaceutical care activities and competen-
cies students were expected to master. The survey layout
recapitulated the 5-stage learning model: [1] learning cli-
mate and preceptor support (9 questions), [2] learning
opportunities (13 questions), [3] patient consultation
estimates (one question), [4] skills improvement (17
questions), and [5] attitude enhancement (29 questions).
In approximate terms, the survey was structured around
the 13 pharmaceutical care competency domains empha-
sized in the community-based APPE (Table 1). In general,
each of the competency domains was assessed three times;
once as a learning opportunity issue, secondly as a skill
improvement topic, and third as an attitude-related mat-
ter. A final question for preceptors alone asked whether
the experience of precepting students had expanded their
own grasp of pharmaceutical care principles and practice.
Instrument development activities focused on verifying
that questionnaire items putatively assigned to preceptor
supports scales, learning opportunities, skills improve-
ment, and attitudes all conformed to generally accepted
scale development criteria, in that they: (1) distinguished
effectively between enhanced and control settings; (2)
demonstrated alpha reliabilities equal to or exceeding the
rule-of-thumb threshold of α = 0.70; (3) converged relia-
bly on their respective specific themes; (4) did not "spill
across" to other themes; and (5) gathered information
unbiased with respect to source (preceptor or student).
Scales and items passing all these tests would be retained
for further refinement in post-pilot refinements and
future iterations of the enhanced APPE model [17,18].
Data collection
Both the students and their primary preceptors completed
retrospective surveys shortly following the completion of
the APPE. As well, both groups were assured that survey
results would not affect the students' final grades. The sur-
vey instructions requested the preceptors in the enhanced
group and students from both groups to reflect back to the
baseline day of their 8-week APPE. The control preceptors
assessed the students over the second 4-week experience.
While both the students and preceptors were asked about
virtually identical topics, the question phrasing was keyed
to the appropriate audience, for example: student items
were phrased in terms of "There were opportunities to ...",
"I believe that..." whereas preceptor items were phrased in
terms of "The rotation provided the student with...", or "I
met with the student to...". Each survey packet consisted
of seven generic Scantron sheets (#70921) overprinted
with instructions, question stems and 5-point response
categories; 'Never' to 'Always', 'No Improvement' to 'Sig-
nificant Improvement' or 'Strongly Disagree' to 'Strongly
Agree'. Surveys were distributed to students and precep-
tors by mail, and returned either by mail or in-person.
Analysis
Scantron survey results were verified, summarized and
analyzed using SPSS. Results of the study's outcomes pro-
gressed though a series of increasingly stringent analyses;
overall summaries (SPSS Frequencies and Descriptives),
differences between enhanced and control arms (t-tests,
ANOVA), differences between preceptor and student
assessments (t-tests, ANOVA) and possible interactions
(ANOVA), reliability and validity estimates of compe-
tency domains and study rationale measures (Reliability),BMC Medical Education 2008, 8:17 http://www.biomedcentral.com/1472-6920/8/17
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and tests of the various scales' abilities to discriminate
between enhanced and control conditions (Discrimi-
nant). For all tests, the a priori level of significance was set
at p ≤ 0.05.
Since the overall objective of the pilot study was to test the
impact on student learning of the enhanced APPE, we
report those overall results first, followed by more
detailed analyses of the learning model components
(learning climate and preceptor support → learning
opportunities + patient consultations → skills improve-
ment → attitude enhancement). Next we report differ-
ences across the 13 domains of pharmaceutical care and
the differential impact of learning in the enhanced and
control settings. Finally, we report the psychometric prop-
erties of the scales we developed to examine these various
aspects of program enhancement and student perform-
ance with a focus on scale refining and streamlining. We
conclude with a number of 'lessons learned' about further
improvements to the APPE, easier data collection proce-
dures and expanded scope of future enhanced APPE.
Results
At the end of the APPE, there were 13 students who com-
pleted the enhanced APPE (treatment arm) and 28 stu-
dents in the two control APPEs (14 in each arm), one
student from the enhanced arm dropped out prior to the
start of the APPE. All sites had one designated primary
preceptor, two sites in each of the three arms had a sec-
ondary preceptor, one site in the treatment arm had two
secondary preceptors. A total of 74 surveys were returned
at the end of the study: 38 from preceptors and 36 from
students. From the preceptor group, 13 (100%) surveys
were returned from the enhanced arm and 11 (78.6%)
from the control arm representing the national partnering
chain and 14 (100%) from the control arm representing
an assortment of pharmacies. From the student group, 13
(100%) surveys were returned from the enhanced arm,
nine (64.3%) from the national chain control arm and 14
(100%) from the control arm representing an assortment
of pharmacies. One student from the control arm left sub-
stantial portions of the survey unanswered and was elim-
inated from further analysis, for a total of 35 useable
student surveys.
Overall Results
Table 2 demonstrates that, overall, student and preceptor
outcomes favored the enhanced APPE structure over the
structure in the control arms. From the students' own per-
spectives and for all 70 measures combined, student
scores in the enhanced APPE outperformed those in the
control arm by about 0.37 points out of a possible five:
(4.16 vs. 3.79; t = 2.33, p < 0.026). Parallel information
from preceptors about their students' overall performance
generally corroborated students' own assessments. For all
70 measures combined, preceptors' assessments showed a
significant 0.39 point advantage for the enhanced APPE,
(4.07 vs. 3.68; t = 2.67, p < 0.011) slightly exceeding stu-
dents' own reports. From students' and preceptors' com-
bined perspectives, the enhanced APPE showed similar
statistical advantages; the enhanced APPE outperformed
the experience in the control arm by 0.38 points (4.11 vs.
3.73; t = 3.59, df = 71, p < 0.001) and showed an overall
18% gain in performance (η2 = 0.179).
The 5-Stage Learning Model
Table 2 also summarizes results for each of the five stages
of the learning model: learning climate and supports,
learning opportunities, patient consultations, skills
improvements, and pharmaceutical care-related attitudes.
The results always favored the enhanced APPE model,
with two-thirds of the comparisons being statistically sig-
nificant. Since ONEWAY Tukey range tests had shown
there were no statistical differences between the two con-
trol groups for either students or preceptors, the two con-
trol arms were collapsed into a single control group for
further analyses.
Students reported statistically significant benefits of the
enhanced APPE in terms of the number of comprehensive
consultations it afforded (16.65 vs. 5.30; t = 7.29, p <
0.000), skills improvements noted (4.21 vs. 3.50; t = 3.05,
p < 0.004) and attitudes favoring pharmaceutical care
principles (4.39 vs. 4.03; t = 2.41, p < 0.021). Preceptors
in the enhanced model reported noted benefits of the
enhanced APPE, the estimated numbers of comprehen-
sive consultations conducted by students (17.50 vs. 8.74;
t = 5.65, p < 0.000), and skills improvement observed
(4.12 vs. 3.22; t = 3.81, p < 0.004). Although more precep-
tors in the enhanced model agreed that their SPEP partic-
ipation "provided [more] opportunity to practice and
improve my pharmaceutical care skills" than did precep-
tors in the control arms, this was not statistically signifi-
cant.
It is also noteworthy that a two-way ANOVA showed gen-
erally no differences between students' self-reports and
those of their preceptors, except for the finding that pre-
ceptors in both the control and enhanced arms signifi-
cantly (F = 5.65, p < 0.020) over-estimated the number of
patient consultations (11.7 vs. 9.5) provided by their stu-
dents (and verified by the SPEP faculty by reviewing doc-
umentation submitted by the students in their portfolio).
Interestingly, the overestimates were greater in the control
settings than in the enhanced APPE, perhaps suggesting
that preceptors' oversight of student experience is less
detailed in controlled settings. As well, there were no treat-
ment-by-group interactions indicating that both students
and preceptors interpreted and responded to the ques-
tions in essentially the same ways.BMC Medical Education 2008, 8:17 http://www.biomedcentral.com/1472-6920/8/17
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Pharmaceutical Care Competency Domains
Table 3 shows that some competencies were much better
learned than others – irrespective of study arm. For ease of
interpretation, the central columns of the table shows
competency means converted to percentages (mean/5) for
overall results as well as for enhanced/control differences,
thus showing the fraction of what was reported to have
been learned as differential percentages of the maximum
that could be reported. Examining all groups combined
(enhanced, control, students, and preceptors), the table
shows that content domains differ considerably in their
respective levels of learning achievement (M%); ranging
from lows of about 40% to highs of near 90%. For exam-
ple, topics such as collecting relevant patient information
(4.38 out of 5) or determining whether patients were manag-
ing their medication regimes (4.17) were readily grasped
while participating in clinics, seminars, projects or presenta-
tions (1.99) or developing professional relationships with other
health-care providers (3.47) were much less well inculcated.
Finally, the bottom row of Table 3 summarizes the overall
student grasp of these 13 competencies and suggests that
about 77% of what could have been reported was
reported. Moreover, it shows that the enhanced rotations
enjoyed about a 7% advantage over the traditional model
Table 2: Student and preceptor results for the 5-component learning model
Perspective Group Mean t-test Significance
Learning Climate and Preceptor Supports (number (n) of items = 9; score range: 2.00 – 5.00)
Students' Control APPE 3.87 1.21 ns
Enhanced APPE 4.21
Preceptors' Control APPE 3.73 1.89 ns
Enhanced APPE 4.07
Learning Opportunities (n items = 13; score range: 2.46 – 4.62)
Students' Control APPE 3.76 0.34 ns
Enhanced APPE 3.82
Preceptors' Control APPE 3.50 1.56 ns
Enhanced APPE 3.79
Estimated Number of Comprehensive Consultations (n items = 1; score range: 1.00 – 17.00)
Students' Control t APPE 5.30 7.29 p < 0.000
Enhanced APPE 16.65
Preceptors' Control APPE 8.74 5.65 p < 0.000
Enhanced APPE 17.50
Skills Improvement (n items = 17; score range: 1.94 – 5.00)
Students' Control APPE 3.50 3.05 p < 0.004
Enhanced APPE 4.21
Preceptors' Control APPE 3.22 3.81 p < 0.001
Enhanced APPE 4.12
Attitudes (n items = 29; score range: 2.90 – 5.00)
Students' Control APPE 4.03 2.41 p < 0.021
Enhanced APPE 4.39
Preceptors' Control APPE 4.16 0.86 ns
Enhanced APPE 4.31
Overall Scale (n items = 70; score range: 2.65 – 4.89)
Students' Control APPE 3.78 2.33 p < 0.026
Enhanced APPE 4.16
Preceptors' Control APPE 3.68 2.67 p < 0.011
Enhanced APPE 4.07BMC Medical Education 2008, 8:17 http://www.biomedcentral.com/1472-6920/8/17
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(F = 11.40, p < 0.001) in bringing students nearer to read-
iness for entry-to-practice.
When comparing the students' experiences between the
enhanced and the control arms for all 13 of the compe-
tency domains, the outcomes consistently favoured the
enhanced model; with six of the 13 competencies being
significantly improved. These included competencies:
"Integrating patient information," "Documenting patient
information," "Prioritizing drug-related problems,"
"Establishing monitoring parameters with patients," "
Patient follow-up by phone or in-person," and "Providing
basic and comprehensive pharmaceutical care." Addition-
ally, the overall index of learning in all 13 pharmaceutical
care competency domains was significantly better for stu-
dents in the enhanced arm (4.13 vs. 3.81; t = 2.15, p <
0.038) than the control arm – an improvement of 6.25%.
The preceptor pattern was slightly different; they reported
significant improvement in seven of the 13 competencies:
"Asking about patient expectations," "Collecting relevant
information," "Integrating patient information," "Docu-
menting patient information," "Establishing monitoring
parameters," "Patient follow-up by phone or in-person,"
"Providing basic and comprehensive pharmaceutical
care," as well as in the overall index of competency
domains (4.04 vs. 3.66; t = 2.61, p < 0.013).
Table 3: Competency domains for learning pharmaceutical care principles and delivery:Overall, enhanced (treatment) and traditional 
(control) scores for students and preceptors combined.
PC Competency Domains Overall Mean Overall Mean % Enhanced Mean % Control Mean % Significancea
Asking about patient expectations 3.84 76.9 82.1 74.0 0.005
Collecting relevant information 4.38 87.6 91.3 85.5 0.036
Integrating patient information 4.08 81.6 89.0 77.6 0.000
Evaluating different treatment options 4.18 82.5 87.4 79.7 0.010
Documenting patient info: continuity of care 3.91 78.3 85.4 74.3 0.001
Prioritizing drug related problems 3.97 79.4 84.6 76.5 0.002
Determining patient experiences: effectiveness 
or undesirable effects of current medications
4.23 84.6 88.5 82.4 0.023
Determining whether patients were managing 
and adhering to their medication regimes
4.17 83.4 87.2 81.3 0.022
Establishing monitoring parameters with 
patients
3.95 78.9 86.2 74.9 0.000
Following-up patients by phone or in-person 3.90 77.9 85.8 73.6 0.000
Developing professional relationships: with 
other health care providers, physicians
3.47 69.5 69.2 69.6 ns
Participating in clinics, seminars, projects or 
presentations
1.99 39.9 37.6 41.1 ns
Providing basic and comprehensive 
pharmaceutical care
4.14 82.7 88.0 79.8 0.001
Overall Index of Content Domain Learning 3.86 77.2 81.7 74.6 0.001
a Indicates significance of the differences observed between the enhanced (treatment) versus traditional (control)
Table 4: Alpha-reliability coefficients, convergent and discriminant estimates for original study scales.
Learning Model: Original Scales Mean* Standard Deviation Number of Items αa rb Scale Biasc Scale Sensitivityd
Learning Climate & Preceptor 
Support
3.92 0.69 9 0.884 0.549 0.110 0.305
Learning Opportunities 3.69 0.55 17 0.884 0.574 0.162 0.180
Patient Consultations (estimated 
number)
10.67 6.66 1 0.475e 0.475 -0.0168 0.520
Skills Improvement 3.68 0.73 17 0.938 0.476 0.118 0.510
Attitude Enhancement 4.19 0.46 29 0.939 0.479 -0.052 0.261
Overall Study Model Scale (original) 3.87 0.47 70 0.959 0.816 0.121 0.410
αa – Cronbach's alpha-reliability, and the index of convergent validity; how well do items converge on each scale's central concept.
rb – Highest correlation with any other scale. Low correlations mean the scale does not duplicate information in other scales.
c – Pearson r with preceptor vs. student. Non-significant r's indicate absence of bias.
d – Pearson r (or eta) with study arm. Positive correlations indicate sensitivity to predicting enhanced clerkship.
e – Since the patient consultation estimate was a single variable measure, its α-reliability estimate is its SMR with the other four indices.BMC Medical Education 2008, 8:17 http://www.biomedcentral.com/1472-6920/8/17
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Instrument Validation
Tables 4 and 5 summarize the broad array of analyses con-
ducted to validate and test the survey instrument. The
accepted criteria of face validity, reliability, discriminant
validity, construct validity, absence of bias, and sensitivity
were all used as benchmarks to determine whether the
survey's items, scales, and psychometric properties
achieved acceptable levels.
Face validity
Face validity tests whether the individual items in any
instrument "make sense" and whether knowledgeable
experts concur that they are "important things to be
asked". The instrument's 70 items were reviewed and ver-
ified by several cycles of item generation, pre-testing and
refinement by this report's first two authors. The guiding
question was always "Is this what we want to know about
student response to the two versions of the APPE, and is
this the way to ask it?" Subsequently, five faculty and five
randomly selected non-study pharmacy students reviewed
the survey items and provided helpful comments on read-
ability and clarity.
Reliability
Reliability analysis examines whether the various items
thought to constitute a scale are well-aligned, consistent
among themselves, and generally corroborate each other.
Contrary items can be refined, rephrased, or eliminated,
although overall reliability measures depend on the
number of items in the scale. The most common index of
scale reliability is Cronbach's alpha (α) and scale develop-
ers strive for reliability measures of 0.70 or greater. Table
4's fourth column (αa) shows that four of the five learning
model scales (preceptor support (0.88), learning opportu-
nities (0.88), skills improvement (0.94) and attitude
enhancement (0.94) far exceed the guideline, indicating
that the individual items within each scale are good oper-
ational measures of the scale's conceptual content while
simultaneously lending strong support to the construct
validity of the scales' conceptual foundations. Since
patient consultations is a single measure count, the con-
cept of scale reliability doesn't apply in the same way,
hence the table entry is its squared multiple correlation
(0.48) with the four remaining scales. In short, the various
scales comprising the 5-step learning model are well oper-
ationalized by the items constituting them.
For the 13 pharmaceutical care competency domains,
their reliabilities are acceptable but not quite so strong
because the number of items in most scales is often only
three or four. For example: "following-up ...(0.76),"
"developing professional relationships ...(0.77)," "partic-
ipating in clinics ...(0.78)," and "providing basic and
comprehensive pharmaceutical care ...(0.84)" are well
operationalized. In contrast, " asking about patient expec-
tations ...(0.27)," "prioritizing about drug-related prob-
lems ...(0.33)" and "determining if patients are
managing/adhering...(0.46)" are less well-anchored. Nev-
ertheless, the reliability of the overall index calculated
across all 13 domains is 0.92, strong by any measure. Thus
the scales derived from the 70-item survey generally
exhibit reliabilities that are "acceptable" to "strong."
Discriminant validity
Discriminant validity analysis tests whether the items in
any one scale are all more closely correlated among them-
selves than with any different scale, in short, do any of the
items "spill over" into the domain of a different scale?
Table 4, column r(b) show that the highest correlations
between any one scale in the learning model and any
other scale are always lower than their respective alpha
reliabilities indicating that each scale converges on its cen-
tral concept and discriminates it from the other scales
[18].
Construct Validity
Construct validity is a 'concept in reverse' [19]. Rather
than querying how well each scale (or construct) is oper-
Table 5: Psychometric properties of revised learning model scales.
Learning Model: Refined Scales Mean Standard Deviation Number of Items αa rb Scale Biasc Scale Sensitivityd
Preceptor Support 3.94 0.69 6 0.847 0.510 0.104 0.336
Learning Opportunities 4.00 0.62 6 0.837 0.510 0.214 0.304
Patient Consultations (estimated number) 10.67 6.66 1 0.475 0.580 -0.182 0.715
Skills Improvement 3.65 0.86 6 0.873 0.520 0.093 0.622
Attitude Enhancement 4.03 0.65 6 0.837 0.520 -0.157 0.393
Overall Study Model Scale (refinedf) 3.89 0.56 25 0.920 0.796 0.057 0.574
Overall Study Model Scale (original)f 3.87 0.47 70 0.959 0.816 0.121 0.410
αa – Cronbach's alpha-reliability, and the index of convergent validity; how well do items converge on each scale's central concept.
rb – Highest correlation with any other scale. Low correlations mean the scale does not duplicate information in other scales.
c – Pearson r with preceptor vs. student. Non-significant r's indicate absence of bias.
d – Pearson r (or eta) with study arm. Positive correlations indicate sensitivity to predicting enhanced clerkship.
e – Since the patient consultation estimate was a single variable measure, its α-reliability estimate is its SMR with the other four indices.
f – Both Refined and Original scales are listed to document that streamlining resulted in no appreciable loss of scale power and efficiency.BMC Medical Education 2008, 8:17 http://www.biomedcentral.com/1472-6920/8/17
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ationalized, it tests the proposition that "given the opera-
tional evidence, how much credibility can be (backwards)
ascribed to the construct (or scale). If the operational evi-
dence is strong, then there are more solid grounds to
accept the notion that "there is such as thing as learning
climate, or learning opportunity, or skills improvement or
attitude enhancement". In this study, the learning climate
total (of 9 items), learning opportunities total (of 17
items), patient consultation estimate, skills improve-
ments total (of 17 items), attitude enhancement total (of
29 items), and the combined study model total (of 70
items) all have strong construct validities as evidenced by
their high corrected item-total correlations (not shown)
and their high α-reliabilities (0.85 and higher). Collec-
tively, these reliability measures and item-total correla-
tions confirm that such concepts as learning climate,
learning opportunities, skills improvement and attitude
enhancement do exist and can be validly inferred from the
response patterns of pharmacy students and their precep-
tors.
Scale bias
Tests for scale bias seek to verify that both individual
items and the scales constructed from them are unbiased
in terms of the respondent who happens to be completing
the survey. In this study, it meant testing that both stu-
dents and preceptors understood and interpreted the
items in essentially the same way. Study results would be
weakened if it could be shown that any of the learning
model scales favoured preceptors over students or vice-
versa. The 'scale bias' column in Table 5 shows that corre-
lations between scale totals and the persons completing
the surveys (students vs. preceptors) are small and non-
significant, hence threats of study outcomes being spuri-
ous results of student/preceptor differences can be ruled
out. Further evidence that preceptors and students saw the
items and scales similarly was obtained by correlating stu-
dent/preceptor pairs' responses across the various practice
locations. In general, preceptor/student pairs concur
about the learning aspects of the APPE: the correlation
between the pairs for combined feature of the overall
learning model was 0.472. The overall correlations across
all components of the model are fractionally higher for
the enhanced pairs (0.495) than for the controls pairs
(0.460), thus confirming that there was general, if loose,
agreement between preceptors and students about when
Learning Opportunities were (or were not) available,
when clinical instructors had (or had not) facilitated in
such as way as to enable students to meet their overall
SPEP objectives, when Skills Improvements had (or had
not) occurred, and when students' Attitudes and Attribu-
tions of Importance favoured (or did not favour) pharma-
ceutical care focused practice.
Scale Sensitivity
To be helpful in testing for differences between enhanced
and control APPE, both survey items and the scales
derived from them must be sensitive to any differences
that do exist. The rightmost column in Table 4 shows that
the estimate of numbers of patient consultations per-
formed was the most sensitive discriminator between peo-
ple in enhanced APPE vs. those in control settings. Skills
improvement, learning climate, attitude enhancement
and learning opportunities showed decreasing sensitivity
to enhanced/control differences. Some 19 of the 70 were
significant and sensitive indicators of enhanced vs. con-
trol differences: 11 from Skills Improvement, five from
Attitude Enhancement, two from Learning Climate and
Number of patient consultations. Disregarding for the
moment the scales into which the 70 items were aggre-
gated, in descending order of sensitivity, the 19 best dis-
criminating items were: number of patient consultations,
patient follow-up, integrating information from patients
with multiple problems, providing comprehensive phar-
maceutical care to patients with few problems, integrating
patient information to identify drug-related problems,
prioritizing drug-related problems, determining patient
experiences regarding drug effectiveness and undesirable
effects, evaluating different treatment options using
guidelines, disaffirming that follow-up is too time-con-
suming, discussing monitoring parameters with patients,
asking patients about their drug therapy expectations,
determining whether patients were managing their medi-
cations, carrying out independent tasks without undue
reliance on the pharmacist, preceptors encouraging stu-
dents to provide patient follow-up, believing that provid-
ing pharmaceutical care gave students a better
understanding of patients drug-related needs, acknowl-
edging that the SPEP rotation was a key factor in stimulat-
ing pharmaceutical care, feeling comfortable with the
process of providing pharmaceutical care, agreeing that
discussing monitoring parameters with patients is impor-
tant, and disagreeing that providing patient follow-up is
beyond a pharmacist's responsibility.
Learning Model Scale Inter-Correlation
Correlations among the scales for learning climate, learn-
ing opportunities, skills improvement, attitude enhance-
ment, and estimated numbers of patient consultations
averaged 0.43, which together with the high intra-scale
alpha reliability suggests that each of these five indices
taps a different repertory of student performances that are
inter-related but uniquely different from each other. Inter-
estingly, it made a less-than-expected-difference whether
these intercorrelations were tested for the enhanced (r =
0.44) or the control respondents (r = 0.33). Similarly,
there was only slightly greater coherence among precep-
tors' assessments (r = 0.53) than among students' (r =
0.37). The general conclusion is the same in all instancesBMC Medical Education 2008, 8:17 http://www.biomedcentral.com/1472-6920/8/17
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– the five measures overlap to yield a reasonably general-
ized index of APPE training effectiveness which is signifi-
cantly higher for the enhanced cohort than their
classmates in either control setting.
Instrument Refinement
Recognizing that completing a 70-item instrument was
time-consuming and tedious for both students and pre-
ceptors, a subsequent phase of analysis tested whether a
more streamlined instrument could be devised, and one
which maximized the scales' differential abilities to dis-
criminate between enhanced APPE and their traditional
counterparts. Table 5 reports the item parameters for
refined learning model scales when only the best-discrim-
inating six items in each scale were included. Four, five
and seven item versions were also tested but scale reliabil-
ities, interscale differentiation, and scale sensitivity were
all optimized with six items per scale. Selecting only those
specific items from each learning model scale which most
clearly distinguished between enhanced and control arms
resulted in improved precision, such that all five refined
scales discriminated significantly between the study's
treatment arms whereas only three of the study's original
scales were significant discriminators. The most common
themes among items in the streamlined scales included:
"patient follow-up," "documenting patient information,"
"providing pharmaceutical care-based care," "prioritizing
drug-related problems," and "determining whether
patients were managing their medications or had new
questions or concerns," all of which reflect generally
higher-level skills of pharmaceutical care practice rather
than the more elementary learning tasks such as asking
about patient expectations, collecting relevant informa-
tion, etc. Streamlining the scales from 70 down to 25
items demonstrated the multiple advantages of brevity,
greater precision, greater sensitivity to treatment improve-
ments, all while maintaining absence of bias.
Discussion
In general, the present study's results demonstrated that
both students' and preceptors' outcomes favored the
enhanced APPE in achieving the overall goals, although in
slightly different fashion. Considering the combined stu-
dent and preceptor outcomes on the full 70-item survey,
the study's results suggested that the enhanced APPE
resulted in about three times as many patient consulta-
tions as did the control experience, together with greater
skills improvement, more favourable pharmaceutical care
focused attitudes and an improved overall program
impact of about 18%. Slight differences resulted when stu-
dent and preceptor data was analyzed separately. For
example, only the preceptor results suggested that stu-
dents in the enhanced APPE were provided with a supe-
rior learning climate compared to students in the control
APPE; and only the student results suggested that the
enhanced APPE students experienced significantly greater
attitude enhancement compare to their counterparts.
Interestingly, the survey did not detect any difference in
learning opportunity from the students' or preceptors'
perspectives. When considering the 13 pharmaceutical
care competency domains around which the APPE was
structured from combined student and preceptor perspec-
tives, all competencies favored the enhanced experience;
and significantly so for all but two of the competencies
(developing professional relationships with other health
providers, physicians and participating in clinics, semi-
nars, projects or presentations).
Past research has shown that curricular innovation is
much more likely to be successful when instructors are
provided with adequate opportunities to become familiar
with the innovations and their rationale [20,21]. This
applies equally well to preceptors asked to support
changes to clinical placements such as those implemented
in the enhanced APPE. Thus, while student accountabili-
ties are spelled out in considerable detail in the SPEP
manual given to students and preceptors in both control
and enhanced APPE, preceptors in the enhanced APPE
received additional education about how to foreground
these expectations. This was accomplished by presenting
the preceptors with suggestions on how to effectively set
student expectations and facilitate student engagement in
the available learning opportunities, as well as a discus-
sion on each of the activities in which the students were
asked to partake. Similarly, students were provided with a
5-day training that consisted of the Faculty discussing the
APPE activities and expectations in detail with the stu-
dents, giving the students the opportunity to spend time
at their respective APPE sites prior to the start of their
experience to familiarize themselves with their commu-
nity pharmacy's processes and structures, initiate relation-
ship and trust building with their preceptor and pharmacy
staff, and allow their preceptor to assess the students' areas
of strengths and weaknesses. Thus, the study instrumenta-
tion was built around procedures and accountability sys-
tems available equally to students and preceptors in both
control and enhanced APPE. The non-difference in learn-
ing opportunity outcomes, but the significant difference
in skills and attitudes indicates that the mere presence of
opportunities is insufficient, but rather being expected to
put them into practice with preceptors' guidance makes
the enhanced model more successful than the traditional
model as confirmed by the rich literature on situated
learning in "communities of practice" [22]. In short, "we
learn what we pay attention to," but when that attention
is guided by explicit accountabilities, regular monitoring,
and preceptor follow-up, the learning is more meaningful
and better integrated [21-24].BMC Medical Education 2008, 8:17 http://www.biomedcentral.com/1472-6920/8/17
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Pharmaceutical Care Competency Domains
In any learning venue, classroom or experiential, there is
always the likelihood that some domains are apt to be bet-
ter mastered than others; and there is instructionally diag-
nostic value in knowing which domains are successfully
learned and which less so, and whether membership in
the enhanced APPE cohort predicts learning gains in some
domains more than others. Irrespective of the study arm,
combined results from both students and preceptors
showed that some of the pharmaceutical care competen-
cies were better learned than others. For example, collect-
ing relevant patient information,  questioning patients to
determine their experiences with drug effectiveness or undesir-
able effects, determining whether they were adhering to their
medication regimens were all reasonably well achieved
(mid 80%). In contrast, participating in clinics, projects,
presentations or seminars was woefully underachieved
(40%) irrespective of study arm. Between those two
extremes, evidence shows clearly greater content mastery
by students in the enhanced APPE; notably in patient fol-
low-up, integrating patient information, documenting for con-
tinuity of care, and establishing monitoring parameters. For
two domains (developing professional relationships with phy-
sicians and other health care providers and participating in
clinics, projects, presentations or seminars), the control
cohort fractionally outperformed the enhanced cohort
but not significantly. In the present study, the finding that
some competencies were better learned than others allows
curriculum planners to focus on areas where more learn-
ing opportunities are required.
Instrument Refinement
From the outset, it was evident that a 70-item survey was
too long and oversampled the relevant content domains.
Issues of frustration, inattention, and non-compliance are
routine consequences of overlong surveys [25]. Neverthe-
less at the outset, it was unclear which items might prove
to be the best indicators of the study's objectives, hence an
initial oversampling was intentional for this proof-of-con-
cept study. While there are many justifiable strategies for
survey streamlining such as (1) item winnowing on the
basis of face validity, (2) selecting only the half-dozen
most reliable items in each scale, (3) scale reduction via
factor analysis, or (4) multi-trait, multi-method matrix
procedures, the overall objective in this study was to max-
imize the discrimination between enhanced and control
APPE and to test for survey items which best accom-
plished that. Consequently, we examined the items within
each learning model scale that demonstrated the highest
enhanced versus control differentiation. In an effort to
rebalance scale "lopsidedness" where some scales had as
few as nine items while others had as many as 29, we
examined results for four, five, six, and seven-item solu-
tions for each of the 5-stage learning model scales. Table
5 shows the results for a six-item version (for each stage)
which maximized the scales' sensitivities while retaining
high alpha-reliabilities and holding scale bias to a mini-
mum. Scale sensitivity (ability to discriminate between
enhanced and control APPE) increased from 0.41 to 0.57
through judicious item selection. This refined combina-
tion of scale items allows accurate discrimination between
enhanced settings and the two different control groups of
89.0% and distinguishes the enhanced from the com-
bined control participants with an accuracy of 96.2%. As
well, all five of the refined learning model scales become
significantly sensitive to enhanced/control differences
whereas in the original scales, only some were.
As before, the number of patient consultations is by far
the best predictor of the enhanced APPE arm member-
ship. In order of descending sensitivity within learning
model scales, Table 6 shows these refined items with sig-
nificance of Learning Model Scale sensitivity in brackets.
In their refined forms, all five of the learning model scales
became significant discriminators between enhanced and
control APPE, and all but one was unbiased in terms of
preceptor versus student differences. Only the estimated
number of patient consultations again showed consistent
overestimating by preceptors (p < 0.007) irrespective of
enhanced vs. control membership. As Table 6 also shows,
certain pharmaceutical care competencies such as docu-
menting, providing follow-up, prioritizing drug-related
problems, monitoring, etc., appear repeatedly – irrespec-
tive of whether they were phrased as Learning Opportuni-
ties, Skills Improvements, or Attitude-related. These are
the pharmaceutical care practice aspects of patient consul-
tations, a good indicator that direct interaction with
patients is a most powerful learning tool.
Limitations
The study's interpretation and its generalization to other
settings need to be viewed with certain cautions. The par-
ticipant sample was both small and select, as befits a pilot
study. Preceptors and students alike were volunteers and
such self-selection may result in a Hawthorne-like upward
drift in both interest and performance. Whether more
mainstream participants (both preceptors and students)
would demonstrate similarly favourable improvements
between enhanced vs. control reports remains to be
tested. The enhanced APPE intervention consisted of two
components: preceptor education and student prepara-
tion prior to the start of the clerkship. One could reason-
ably question how much of the improved learning that
was observed could have been the result of increased stu-
dent preparation compared to preceptor training. The cur-
rent study design and participant numbers do not allow a
direct analysis of their reciprocal effects, and future inves-
tigation is planned. The study was retrospective in its con-
ceptualization whereas pre/post designs coupled with
enhanced/control conditions offer more explanatoryBMC Medical Education 2008, 8:17 http://www.biomedcentral.com/1472-6920/8/17
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power. The study's 70-item Scantron questionnaire pre-
sented some disadvantages. Questions and their
responses were overprinted on about every third line of
the Scantron bubbles resulting in alignment problems
both in terms of printing and ease of reading. Future stud-
ies will ensure that respondents have the sole task of inter-
preting the questions and generating accurate responses
while the researchers will accept the task of assigning scale
numbers to conceptual categories even though it results in
more laborious data entry. Also, 70 questions are
undoubtedly too many resulting in respondent fatigue
and loss of interest. Judicious combinations of reliability
and discriminant analyses with larger and more represent-
ative samples will allow even further streamlining such
that future questionnaires are shorter, more targeted and
more focused, probably in the 20-to-30 item (and 6 or 7
domain) range of well-validated clinical learning instru-
ments such as Stanford University's SFDP-26 or Cleveland
Clinic's Teaching Effectiveness Instrument measures
[26,27]. Finally, the learning of competencies was
assessed, in part, by student self-report. It could be argued
that it is in a student's best interest to report that learning
has taken place, and that this motivation might be greater
after a 5-day intervention. It was reassuring, therefore, to
discover that comparisons of the students' perceptions of
their learning to those of the preceptors were not statisti-
cally different. It can also be argued that student self-
report and, more generally, the opportunities for students
to reflect on their own learning, are vital components of
programs such as the ones presented here.
Conclusion
In summary, the proof-of-concept examination showed
that the enhanced arm generated higher overall results
than did the control arms, with specifically higher scores
in student views about patient consultations, skills
improvement and attitudes toward pharmaceutical care
practice. Similarly, preceptors reported increased precep-
tor supports, numbers of patient consultations, student
skills improvement, and enhanced student attitudes.
These study outcomes helped the SPEP faculty to secure
funding from several additional community pharmacy
chains within British Columbia to further develop, evalu-
ate and expand the enhanced APPE to other preceptors
and students in future years. Concurrent with develop-
ment of the enhanced APPE's rationale and operational
realities, an assessment instrument was developed,
reviewed and refined which was closely keyed to the
requirements and expectations of SPEP objectives. Also,
the psychometric properties of the assessment survey were
examined during this first iteration of the enhanced SPEP
rotation and shown to be generally supportive of the pro-
Table 6: Refined scale composition with the six best-discriminating items per scale.
Number of patient Consulted: (F = 41.35, p < 0.000)*. • Estimated number of consultations.
Learning Climate: (F = 3.88, p < 0.026). • Preceptor encouraged patient follow-up.
• SPEP was significant in stimulating PC delivery to patients.
• Preceptor met with me on a regular basis to talk about patient issues.
• Clerkship gave me opportunities to practice and improve my PC skills.
• Preceptor identified activities for me to meet PC learning objectives.
• Preceptor encouraged me to provide evidence and justify my recommendations.
Learning Opportunities: (F = 3.23, p < 0.046). • Document patient information in forms usable by other pharmacists.
• Provide follow-up (phone or in-person) using the monitoring plan.
• Discuss monitoring parameters with patients regarding their therapies.
• Determine whether patients are managing their medications or have questions.
• Prioritize drug-related problems so that most relevant problems get addressed first.
• Question patients to determine their experiences regarding drug effectiveness.
Skills Improvement: (F = 20.69, p < 0.000). • Provide follow-up (phone or in-person) using the monitoring plan.
• Integrate information for patients with multiple problems to identify drug-related 
problems.
• Provide comprehensive PC to patients with fewer problems (4 or less).
• Integrate patient information to identify actual/potential drug-related problems.
• Prioritize drug-related problems so most relevant problems get addressed first.
• Document patient information in forms to be used by other pharmacists/practitioners.
Attitude Enhancement: (F = 6.86, p < 0.002). • Disagrees: Follow-up is too time-consuming.
• Providing PC gives me a better understanding of patients' drug-related needs.
• Agrees: I am comfortable with the process of providing PC.
• Discussing monitoring parameters with patients is important.
• Disagrees: Follow-up is too expensive.
• Documenting care plans for continuity of care is important.
* F and p values indicate the significance with which each scale discriminated between enhanced and control experiences.BMC Medical Education 2008, 8:17 http://www.biomedcentral.com/1472-6920/8/17
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gram's conceptual underpinnings – both in terms of
learning process and of pharmaceutical care content
domains. Finally, scale refinement analyses pointed to the
need for briefer and more precise scales of clerkship learn-
ing and experience.
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